Literature DB >> 1412932

Living related and cadaver donor liver transplantation.

M Haberal1, R Tokyay, H Telatar, N Buyukpamukcu, H Simsek, B Kayhan, G Arslan, N Bilgin, E Ekici, B Uzunalimoglu.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1412932

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  4 in total

1.  Empirical and normative aspects of medical technology assessment. The case of reduced-size liver transplantations with living donors.

Authors:  G J Van der Wilt
Journal:  Theor Med       Date:  1995-09

2.  Amifostine enhances the antioxidant and hepatoprotective effects of UW and HTK preservation solutions.

Authors:  Sami Akbulut; Sinasi Sevmis; Hamdi Karakayali; Nilüfer Bayraktar; Muge Unlukaplan; Ergun Oksuz; Atilla Dagdeviren
Journal:  World J Gastroenterol       Date:  2014-09-14       Impact factor: 5.742

3.  Adult living donor liver transplantation: body mass index and MELD score of recipients are independent risk factors for hospital mortality.

Authors:  Tung-Yu Tsui; Marcus N Scherer; Andreas A Schnitzbauer; Hans J Schlitt; Aiman Obed
Journal:  Langenbecks Arch Surg       Date:  2008-05-30       Impact factor: 3.445

4.  Donor safety in living donor liver transplantation: a single-center analysis of 300 cases.

Authors:  Jianyong Lei; Lunan Yan; Wentao Wang
Journal:  PLoS One       Date:  2013-04-25       Impact factor: 3.240
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.